Our previous study suggested that over-expression of aspartyl (asparaginal) beta-hydroxylase (ASPH) in tumor tissue is closely associated with invasiveness and recurrence of HCC [6]. This evidence concerns the gene ASPH and hepatocellular carcinoma.